Group Single Webinar Registration
- Contains 3 Component(s), Includes Credits Includes a Live Web Event on 12/13/2023 at 2:00 PM (EST)
This presentation will review the use of costal cartilage allografts in reconstructive ear procedures. We will discuss conditions and scenarios requiring reconstruction, surgical reconstruction options, costal graft preparation, and examples of reconstructive ear procedures.
- Contains 163 Product(s) 1 new product(s) added recently
Save your staff time and money when you take advantage of the AATB Group Webinar Series Subscription. With one registration, your entire company will gain access to all AATB webinar programming for the whole year.
- Contains 162 Product(s) 1 new product(s) added recently
Take advantage of the AATB Individual Webinar Series Subscription providing individual access to an entire year of educational programming.
- Contains 3 Component(s) Includes a Live Web Event on 12/06/2023 at 2:00 PM (EST)
The tissue banking industry is undergoing an “era of opportunity” as the need for supplying the medical field with a variety of regenerative medicine solutions increases. As the regulatory paradigm has evolved, so have days of tissue banks marketing products exclusively regulated as Section 361 Human Cells, Tissues, and Cellular and Tissue-Based Products. In a regulatory world where tissue may be regulated as a Section 361 HCT/P, as a Section 351 HCT/P, or even as a medical device, the requirements for reporting adverse outcomes have never been more confusing to new and existing players in this emerging regulatory space for industry. Join John Mayhall, the Mayor of Regulationville, and Kip Hanks, AATB Director of Regulatory and Governmental Affairs, as we navigate the many regulatory pathways and requirements for human tissue product adverse outcomes reporting.
|Access Date||Quiz Result||Score||Actions|